Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neosante Health Solutions is a Portuguese healthcare company specializing in the development and commercialization of innovative health products, including food supplements, medical devices, and cosmetics. Founded in 2007 and based in Lisbon, the company focuses on therapeutic areas such as gastroenterology, pediatrics, and the central nervous system. Their flagship product, Delictase, is a widely used lactase enzyme supplement designed to manage infant colic caused by lactose intolerance. Neosante maintains a strong international presence, exporting its evidence-based portfolio to over 20 countries across multiple continents. The company leverages strategic partnerships to expand its global footprint while maintaining a focus on high-quality, scientifically-backed formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neosante Health Solutions.